BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS

Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkyny...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GIACHETTI, ANTONIO, TURCONI, MARCO, MONTAGNA, ERNESTO, NICOLA, MASSIMO, DONETTI, ARTURO, UBERTI, ANNAMARIA, MICHELETTI, ROSAMARIA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GIACHETTI, ANTONIO
TURCONI, MARCO
MONTAGNA, ERNESTO
NICOLA, MASSIMO
DONETTI, ARTURO
UBERTI, ANNAMARIA
MICHELETTI, ROSAMARIA
description Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA1337347C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA1337347C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA1337347C3</originalsourceid><addsrcrecordid>eNqFyrEOgjAQgGEWB6M-g_cCHbAa5uM45BJsTVtAWQgxdTJKgu8fHdxd_m_5l0mXs-nlJAX2thbDaqfst6kidLm9XGshQJICCnbSYpCWPTSey6YG9HBQVQDHxOdgHaAJeLRGfPDrZHEfH3Pc_Fwl25IDVSpOryHO03iLz_geCFOtM73PSP8_Pu2LL_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</creator><creatorcontrib>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</creatorcontrib><description>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</description><edition>6</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951017&amp;DB=EPODOC&amp;CC=CA&amp;NR=1337347C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951017&amp;DB=EPODOC&amp;CC=CA&amp;NR=1337347C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GIACHETTI, ANTONIO</creatorcontrib><creatorcontrib>TURCONI, MARCO</creatorcontrib><creatorcontrib>MONTAGNA, ERNESTO</creatorcontrib><creatorcontrib>NICOLA, MASSIMO</creatorcontrib><creatorcontrib>DONETTI, ARTURO</creatorcontrib><creatorcontrib>UBERTI, ANNAMARIA</creatorcontrib><creatorcontrib>MICHELETTI, ROSAMARIA</creatorcontrib><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><description>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEOgjAQgGEWB6M-g_cCHbAa5uM45BJsTVtAWQgxdTJKgu8fHdxd_m_5l0mXs-nlJAX2thbDaqfst6kidLm9XGshQJICCnbSYpCWPTSey6YG9HBQVQDHxOdgHaAJeLRGfPDrZHEfH3Pc_Fwl25IDVSpOryHO03iLz_geCFOtM73PSP8_Pu2LL_U</recordid><startdate>19951017</startdate><enddate>19951017</enddate><creator>GIACHETTI, ANTONIO</creator><creator>TURCONI, MARCO</creator><creator>MONTAGNA, ERNESTO</creator><creator>NICOLA, MASSIMO</creator><creator>DONETTI, ARTURO</creator><creator>UBERTI, ANNAMARIA</creator><creator>MICHELETTI, ROSAMARIA</creator><scope>EVB</scope></search><sort><creationdate>19951017</creationdate><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><author>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA1337347C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GIACHETTI, ANTONIO</creatorcontrib><creatorcontrib>TURCONI, MARCO</creatorcontrib><creatorcontrib>MONTAGNA, ERNESTO</creatorcontrib><creatorcontrib>NICOLA, MASSIMO</creatorcontrib><creatorcontrib>DONETTI, ARTURO</creatorcontrib><creatorcontrib>UBERTI, ANNAMARIA</creatorcontrib><creatorcontrib>MICHELETTI, ROSAMARIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GIACHETTI, ANTONIO</au><au>TURCONI, MARCO</au><au>MONTAGNA, ERNESTO</au><au>NICOLA, MASSIMO</au><au>DONETTI, ARTURO</au><au>UBERTI, ANNAMARIA</au><au>MICHELETTI, ROSAMARIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><date>1995-10-17</date><risdate>1995</risdate><abstract>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA1337347C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A54%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GIACHETTI,%20ANTONIO&rft.date=1995-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA1337347C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true